Q4 2022 Hypera SA Earnings Call Transcript
Good morning Ladies and gentlemen, and welcome to the Hypera Pharma's conference call where we will discuss our earnings for 2022. We have with us Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, IRO. We'd like to inform you that this event is being recorded. You may access a recording of it in the company's Investor Relations website, hypera.com.br/ri. (Operator Instructions)
Before we continue, we'd like to underscore that some of the information in this conference call may refer to projections or statements on future expectations. This information is subject to known and unknown risks and uncertainties that may make them not come to pass or to be substantially different from what was expected. Now we'd like to give the floor to Mr. Breno Oliveira, who will begin the company's presentation. Mr. Breno, over to you.
Good morning, everyone. Welcome to our earnings call for 2022 and for the fourth quarter of 2022. Last year was a very special one for Hypera. We reached all the guidance
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |